The Drosophila gene jim was identi®ed by an enhancer trap line showing asymmetric dorso-ventral expression in the follicular epithelium. It gives rise to the jim-1 and jim-2 transcripts that contain distinct 5
Results and discussion
The jim OVK line was selected during a screening for enhancer trap lines showing speci®c expression of the lacZ reporter gene in various subpopulations of follicle cells. From stage 10 of oogenesis, this line displays speci®c expression of the reporter gene in a population of nonantero-dorsal columnar (NADC) cells complementary to the antero-dorsal columnar (ADC) cells where the DER pathway is activated (Nilson and Schu Èpbach, 1999) (Fig.  1) . In situ hybridization studies, using RNA probes derived from subclones of genomic DNA fragments¯anking the P[lac;w] insertion, provided evidence for the existence of a transcription unit, jim, expressed in NADC cells in stage 10 follicles ( Fig. 2A, C±E) . A combination of northern blot analysis ( Fig. 3 and data not shown), cDNA sequencing and transcript mapping showed that the jim locus gives rise to two transcripts, jim-1 (5.5 kb) and jim-2 (6.5 kb), from alternative transcription start sites (Fig. 2B ). Both RNAs are expressed in ovaries and in late (8-to 20-h-old) embryos (Fig. 3A,B) , and encode the same nine zinc ®nger protein (Fig. 4A,B) (sequence accession no. AJ133756).
A single 115 kDa Jim protein was detected by western blotting of ovarian protein extracts (Fig. 4C) . At all stages of oogenesis, the pattern of accumulation of the Jim protein paralleled the expression of the lacZ reporter gene in the jim OVK line (Fig. 5 ) with the exception that the Jim protein was also detected in squamous cells from stage 9 onward ( Fig. 5C±E ) and in a single row of 10±15 ADC cells in stage 12 follicles (Fig. 5E ). In stage 15 embryos, Jim accumulated in the anterior midgut and hindgut and in glossopharyngeal muscles (Fig. 5I) .
In ovaries from homozygous jim OVK females, because the jim-2 RNA was not detectable (Fig. 3C ) due to transcription arrest within transposon sequences (Fig. 3D) , it can be concluded that Jim accumulation resulted almost exclusively from the translation of the jim-1 transcript. In the germarium and in stage 1 to 6/7 egg chambers, the pattern of Jim accumulation was similar to that in wild-type ovaries (data not shown), but it differed dramatically at later stages with Jim being undetectable in posterior follicle cells at stages 8 to 9 (data not shown), and in NADC cells at stages 10A to 12 (5F± H). These data strongly suggest that jim-1 RNA is expressed in squamous cells from stage 9 and in the row of ADC cells in stage 12 follicles and that jim-2 is transcribed in NADC cells from stage 10A (Fig. 2C±E) . In homozygous jim OVK females, Jim accumulation was also observed in ADC cells between stages 10A to 11 (Fig. 5F ,G) where no expression of the protein was detected in the wild-type context (Fig. 5C,D) . This correlated the ectopic expression of jim-1 RNA in the ADC cell region in stage 10A/B follicles (Fig. 2F) .
In gurken mutant follicles in which the DER pathway was not activated, Jim was expressed throughout the columnar epithelium with the exception of a small region at the posterior pole populated by cells having acquired an anterior E-mail address: yanicostas@ijm.jussieu.fr (C. Yanicostas) identity because of the lack of Gurken signal (Gonza Ález- Reyes et al., 1995; Roth et al., 1995) (Fig. 6B ). In fs(1)K10 mutant follicles, Jim accumulated throughout columnar follicle cells except for a 4 to 5 cell-wide domain surrounding the anterior region of the oocyte (Fig. 6C ).
Experimental procedures

Drosophila stocks
The jim OVK line was identi®ed among a collection of 700 independent lines containing autosomic insertions of the P[lac;w] transposon (Bier et al., 1989) . The grk DC (Schu Èp-bach, 1987) , grk 2B6 (Neuman-Silberberg and Schu Èpbach, 1993) and fs(1)K10 LMOO (Cheung et al., 1992 ) stocks were used. The w 1118 stock was used as wild-type control.
Molecular techniques
Genomic DNA fragments¯anking the transposon insertion site were cloned by plasmid rescue (Pirrotta, 1986) . Screening of ovarian cDNA libraries (Stroumbakis et al., 1994; Hazelrigg and Tu, 1994; Couderc and Laski, unpublished data) was carried out according to standard procedures (Sambrook et al., 1989) . In addition, the EST clone GM 05638 (Berkley Drosophila Genome Project) was identi®ed as a jim cDNA.
Poly A 1 RNA was isolated using RNeasy and Oligotex mRNA kits (Qiagen). Northern analysis was carried out as described in Yanicostas et al. (1989) except that RNA probe synthesis, and northern blot hybridization and dehybridization were performed using the Strip-EZ kit (Ambion). RACE experiments were carried out using the Marathon cDNA Ampli®cation kit (Clontech). RT-PCR experiments were performed using random hexamers and Expand MMLV reverse transcriptase (Boehringer Mannheim). PCR ampli®ed fragments were cloned into the pGEM-T easy vector (Promega). jim cDNA and genomic DNA subclones were sequenced using the Thermosequenase cycle sequencing kit (Amersham Pharmacia Biotech).
Anti-Jim antibodies and Western blotting
Polyclonal antibodies were raised in New Zealand female rabbits against a non-zinc ®nger domain of the Jim protein (amino acids 134±308) fused to the GST protein in the pGEX bacterial expression vector (Amersham Pharmacia Biotech) and puri®ed on a Glutathione Sepharose 4B matrix (Amersham Pharmacia Biotech). Antibodies were immunoaf®nity puri®ed through GST and GST-Jim coupled Sepharose 4 (Amersham Pharmacia Biotech) columns. Chemiluminescent western blot detection of the Jim protein in ovarian and embryonic extracts was performed with the ECL kit (Amersham Pharmacia Biotech). Anti-Jim and goat anti-rabbit horseradish peroxydase-conjugated secondary antibodies (Vector) were used at 1:750 and 1:1600 dilutions, respectively.
X-Gal staining, whole-mount in situ hybridization and immunocytochemistry
X-gal staining of whole mount ovaries were carried out as described previously (Yanicostas et al., 1995) . Wholemount RNA in situ hybridization of ovaries and embryos was carried out according to Tautz and Pfei¯e (1989) with minor modi®cations (Suter and Steward, 1991) . Digoxigenin-labelled antisense RNA probes were synthesized using the RNA Genius kit (Boehringer Mannheim). Immunodetection of the Jim protein in whole-mount ovaries was performed according to Se Âgalat et al. (1992) . Anti-Jim and OVK¯i es were viable and fertile, but 17% of the eggs laid did not hatch as compared to 7% in the case of a wild-type stock. This reduced fertility was not associated with any detectable phenotype. anking the insertion site of the P[lac;w] transposon at 79F1-2. Subclones (b4, b3.1, b3.2) used for synthesizing RNA probes, that gave no signal above background by in situ hybridization of whole-mount ovaries, are indicated as empty boxes. All probes from b3 to s3 hybridized to sequences transcribed in NADC cells in stage 10 follicles and displayed either a cytoplasmic [b3, b3.3, s2, s3, s2.1, s2.2 and s2.3 (black boxes)] or a nuclear pattern of transcript accumulation [b2, b1 and s1 (grey boxes)] according to their exonic or intronic nature. (B) Structure and direction of transcription (broken arrows) of the jim-1 and jim-2 RNA deduced from ovarian cDNA sequencing and transcript mapping data. Untranslated exonic sequences (empty boxes), the putative ORF (black boxes) and introns (broken lines) are indicated. The 0.9 kb RNA detected by northern blotting using the b3.3 probe is not represented. While the jim RNAs differ by their 5 H -UTRs (351 bp for jim-1 and 1880 bp for jim-2), the possibility that they also differ by their 3 H -UTR could not be ruled out. (C±F) Whole-mount in situ hybridization of stage 10A/B follicles from w 1118 (C±E) or jim OVK /jim OVK (F) females using RNA probes synthesized from subclones b3.3 (C), b1 (D) and s3 (E,F). The staining observed in the nurse cells with the b1 and s3 probes corresponds to non-speci®c background signal. In (F), the arrow indicates ectopic accumulation of the jim-1 RNA in the ADC cell region.
goat anti-rabbit horseradish peroxydase-conjugated secondary antibodies (Vector) were diluted 1:750 and 1:400, respectively. 
